UNSPSC 51302333: Enilconazole sulfate

This classification denotes an antifungal agent with the molecular formula C14H14Cl2N2O.H2O4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier G2BD9F4H2H, chemically known as 1h-imidazole, 1-(2-(2,4-dichlorophenyl)-2-(2-propen-1-yloxy)ethyl)-, sulfate (1:1), but more generally known as enilconazole sulfate, which bears US NIH Compound Identifier 173636. European Medicines Agency schedules enilconazole sulfate or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06533MIG.

Most nations, for tariff purposes, schedule enilconazole sulfate under HS 29332990. SMILES: C=CCOC(CN1CCNC1)C2CCC(CC2CL)CL.OS(=O)(=O)O.

UNSPSC 51302333 Enilconazole sulfate (Commodity) covers antifungal pharmaceutical agents, though recent state and local procurement activity under this code shows limited scope alignment. The City of Tampa Fire Rescue Department posted an ITB in April 2026 for medical aid supplies that includes a broad range of first aid and emergency medical items — antiseptic sprays, hydrogen peroxide, pain relievers, bandages, first aid kits, and emergency blankets — rather than enilconazole sulfate specifically. The solicitation encompasses 32 distinct medical and first aid supply line items with estimated annual quantities ranging from 1 to 2,700 units per product, suggesting this code may serve as a catchall classification for miscellaneous pharmaceutical and medical supply procurement rather than targeting enilconazole sulfate as a distinct active ingredient. The procurement indicates that issuing bodies in this space include city fire and rescue departments pursuing supplies through standard ITB processes with multi-year award structures.

The Tampa opportunity, with a total department budget of $100,000 and a one-year initial award period with two optional one-year renewals, represents the recent documented activity under this code. The City of Tampa included set-aside provisions for City-certified Small Local Business Enterprises (SLBEs) and Underutilized Woman and Minority Owned Business Enterprises (U-WMBEs), offering a 5% bid discount capped at $10,000 for SLBEs and $20,000 for U-WMBEs, with a pre-compiled contact list of 11 certified minority and small local business enterprises. All medications required a minimum nine-month expiration date from acceptance, and bidders had to submit a Letter of Intent within ten work days of the April 9, 2025 bid opening. The code shows minimal recent activity and poor alignment between its nominal pharmaceutical focus and the actual medical supply mix being procured.